Fudan University
🇨🇳China
- Country
- 🇨🇳China
- Ownership
- Private
- Established
- 1905-01-01
- Employees
- 1K
- Market Cap
- -
- Website
- http://www.fudan.edu.cn
R-ESHAP Followed by Autologous Transplantation for Refractory or Relapsed Diffused Large B-cell Lymphoma
Phase 2
- Conditions
- Diffuse Large B-cell Lymphoma
- Interventions
- Drug: R-ESHAP
- First Posted Date
- 2011-01-19
- Last Posted Date
- 2013-03-05
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 50
- Registration Number
- NCT01278602
- Locations
- 🇨🇳
Fudan University Shanghai Cancer Center, Shanghai, China
The Efficacy and Safety of Anticoagulation in Chinese Patients With Non-ST Segment Elevation Acute Coronary Syndrome
- Conditions
- Acute Coronary Syndrome
- First Posted Date
- 2011-01-06
- Last Posted Date
- 2011-01-06
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 1800
- Registration Number
- NCT01271101
- Locations
- 🇨🇳
School of Public Health, Fudan University, Shanghai, Shanghai, China
Clinical Study of Sorafenib and Zoledronic Acid to Treat Advanced HCC
- First Posted Date
- 2010-12-14
- Last Posted Date
- 2011-04-14
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 50
- Registration Number
- NCT01259193
- Locations
- 🇨🇳
Liver Cancer Institute, Shanghai, Shanghai, China
The Efficacy and Safety of Salmeterol/Fluticasone Propionate vs Atropium/Albuterol in Patients COPD
Phase 4
- Conditions
- Chronic Obstructive Pulmonary Disease (COPD)
- Interventions
- Drug: Salmeterol/Fluticasone Propionate
- First Posted Date
- 2010-11-19
- Last Posted Date
- 2010-11-19
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 450
- Registration Number
- NCT01243788
- Locations
- 🇨🇳
Henan Province Hospital, Zhengzhou, Henan, China
🇨🇳Affiliated Hospital of Anhui Medical College, Hefei, Anhui, China
🇨🇳Beijing Chaoyang Hospital, Beijing, Beijing, China
Efficacy and Safety Study of Neoadjuvant Chemotherapy for Local Advanced Triple Negative Breast Cancer Patients
- Conditions
- Triple Negative Local Advanced Breast Cancer
- First Posted Date
- 2010-10-07
- Last Posted Date
- 2010-10-07
- Lead Sponsor
- Fudan University
- Registration Number
- NCT01216124
Adjuvant Platinum and Taxane in Triple-negative Breast Cancer (PATTERN)
Phase 3
Completed
- Conditions
- Triple Negative Breast Cancer
- Interventions
- First Posted Date
- 2010-10-07
- Last Posted Date
- 2020-05-19
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 647
- Registration Number
- NCT01216111
Incidence of Hepatitis B Virus (HBV) Reactivation in HBsAg Negative/HBcAb Positive Lymphoma Patients Treated With RCHOP
Phase 2
- Conditions
- Lymphoma
- Interventions
- Drug: nucleoside analog reverse transcriptase inhibitor
- First Posted Date
- 2010-09-28
- Last Posted Date
- 2014-01-08
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 110
- Registration Number
- NCT01210287
- Locations
- 🇨🇳
Fudan University Shanghai Cancer Center, Shanghai, Shanghai, China
🇨🇳Fudan University Cancer Hospital, Shanghai, Shanghai, China
Transcranial Alternating Current Stimulation
Phase 4
Completed
- Conditions
- Stroke
- Interventions
- Device: transcranial alternating current stimulation (tACS)
- First Posted Date
- 2010-09-14
- Last Posted Date
- 2010-09-14
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 312
- Registration Number
- NCT01200719
- Locations
- 🇨🇳
Huashan Hospital, Shanghai, Shanghai, China
S-1/Leucovorin (SL) Versus sLV5FU2 as the First-line Treatment for Elderly Patients With Colorectal Cancer
Phase 2
- Conditions
- Colorectal Cancer
- Interventions
- Drug: S-1, Leucovorin
- First Posted Date
- 2010-09-02
- Last Posted Date
- 2010-09-02
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 100
- Registration Number
- NCT01193452
- Locations
- 🇨🇳
Jin Li', Shanghai, Shanghai, China
Study of Endostatin Combined With Docetaxel in the Treatment of Advanced Non-small Cell Lung Cancer Patients
Phase 2
- Conditions
- Carcinoma, Non-Small-Cell Lung
- First Posted Date
- 2010-09-01
- Last Posted Date
- 2010-09-16
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 30
- Registration Number
- NCT01192230
- Locations
- 🇨🇳
Cancer hospital Fudan University, Shanghai, Shanghai, China
© Copyright 2025. All Rights Reserved by MedPath